|
MechanismSGLT2 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Guangzhou Continent Biomedical Technology Co., Ltd.
0 Patents (Medical) associated with Guangzhou Continent Biomedical Technology Co., Ltd.
100 Deals associated with Guangzhou Continent Biomedical Technology Co., Ltd.
100 Translational Medicine associated with Guangzhou Continent Biomedical Technology Co., Ltd.